Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

16,920.00ZAc
16 Oct 2018
Change (% chg)

749.00 (+4.63%)
Prev Close
16,171.00
Open
16,175.00
Day's High
16,976.00
Day's Low
16,175.00
Volume
1,892,430
Avg. Vol
1,641,954
52-wk High
32,750.00
52-wk Low
15,079.00

Chart for

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.38 30.95 32.69
EPS (TTM): 11.17 -- --
ROI: 6.19 14.77 14.32
ROE: 11.92 16.27 16.04

Aspen Pharma suffers week of woe as valuation tumbles by $3 bln

* Investors spooked by debt levels and sale of baby milk business

21 Sep 2018

Drugmaker Aspen sells baby milk business to dairy giant Lactalis

JOHANNESBURG Aspen Pharmacare has agreed to sell its infant formula business to Lactalis for 12.9 billion rand (660.64 million pounds) to focus on core activities while the French buyer looks to revive its baby milk expansion after a health scandal.

13 Sep 2018

South Africa's Aspen sells infant formula business to Lactalis for $865 million

JOHANNESBURG African drugmaker Aspen Pharmacare has agreed to sell its infant formula business to French dairy group Lactalis for 12.9 billion rand ($865 million), looking to capitalise on the sector's recent flurry of dealmaking to reduce its debt and focus on core operations.

13 Sep 2018

Lactalis says Aspen deal to boost overseas business

PARIS Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

13 Sep 2018

Lactalis says Aspen deal to boost overseas business

PARIS, Sept 13 Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

13 Sep 2018

UPDATE 3-South Africa's Aspen in talks to sell infant formula unit

JOHANNESBURG, Sept 11 Aspen Pharmacare is in talks to sell its global infant formula business, it said on Tuesday, as the South African drug maker seeks to cash in on growing demand for baby milk.

11 Sep 2018

South Africa's Aspen mulls sale of infant formula unit

JOHANNESBURG, Sept 11 South African drug maker Aspen Pharmacare said on Tuesday it was in discussions to sell its global infant formula business, but did not give any further details.

11 Sep 2018

South African drugmaker Aspen secures 3.4 billion euro credit line

JOHANNESBURG, May 17 Aspen Pharmacare, Africa's biggest generic drugmaker, said on Thursday it had secured a 3.4 billion euro ($4 billion) credit facility for refinancing debt at three of its subsidiaries.

17 May 2018

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

07 May 2018

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa, May 7 South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

07 May 2018

Earnings vs. Estimates